Publication | Open Access

Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non‐valvular atrial fibrillation from the RE‐LY trial

ThrombosisCardiovascular DiseaseMedicineHematologyCardiovascular PharmacologyPopulation Pharmacokinetic AnalysisPharmacotherapyCoagulopathyRe‐ly TrialNon‐valvular Atrial FibrillationPharmacologyAnticoagulantCardiology